This is the limited version of the Spherics company profile: Join LinkedIn or Sign In to see more information.
Spherics, Inc., a pharmaceutical company, develops drugs for the treatment of central nervous system disorders, gastrointestinal disorders, and cancer. Its product pipeline includes SRx-501 and SRx-503 for Parkinson's disease, SRx-502 for Anti-Migraine, SRx-504 for Epilepsy, SRx-505 for chronic pain, and SRx-506 for Neuropathic pain. Spherics also collaborates with pharmaceutical companies in life-cycle management and product line extension. The company was founded in 1997 and is headquartered in Mansfield, Massachusetts.
Your Connections to Spherics
375 Forbes Boulevard
Mansfield, MA
02048
United States
Phone: 508-452-7000
Secondary Phone: 866-862-4383
Fax: 508-452-7070
| Industry | Pharmaceuticals |
|---|
| Type | Privately Held |
|---|
| Status | Operating |
|---|
| Company Size |
11-50 employees |
|---|
| Founded | 1997 |
|---|
| Website | http://www.spherics.com |
|---|
Estimated based on LinkedIn Data
In partnership with 
Send feedback on BusinessWeek/CapIQ content to linkedinissues@capitaliq.com Copyright © 2008 Capital IQ
This LinkedIn Company Profile was created by LinkedIn and is about Spherics. This page is not endorsed by or affiliated with Spherics. For questions regarding LinkedIn Company Profiles, contact us.
| 